Cargando…
The Expression of CD30 Based on Immunohistochemistry Predicts Inferior Outcome in Patients with Diffuse Large B-Cell Lymphoma
The prognostic value of CD30 expression indiffuse large B-cell lymphoma (DLBCL)remains controversial. Herein, we performed this retrospective study to investigate the clinical and prognostic significance of CD30 expression in patients with DLBCL.Among all the 146 patients, the expression of CD30 was...
Autores principales: | Hao, Xiaoxiao, Wei, Xiaolei, Huang, Fen, Wei, Yongqiang, Zeng, Hong, Xu, Linwei, Zhou, Qinjun, Feng, Ru |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4431801/ https://www.ncbi.nlm.nih.gov/pubmed/25974110 http://dx.doi.org/10.1371/journal.pone.0126615 |
Ejemplares similares
-
Consecutive Hypoalbuminemia Predicts Inferior Outcome in Patients With Diffuse Large B-Cell Lymphoma
por: Wei, Xiaolei, et al.
Publicado: (2021) -
Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B-cell lymphoma
por: Hao, Xiaoxiao, et al.
Publicado: (2017) -
LINC00908 Promotes Diffuse Large B-Cell Lymphoma Development by Down-Regulating miR-671-5p
por: Zeng, Hong, et al.
Publicado: (2021) -
The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Wei, Xiaolei, et al.
Publicado: (2017) -
Publisher Correction: The international staging system improves the IPI risk stratification in patients with diffuse large B-cell lymphoma treated with R-CHOP
por: Wei, Xiaolei, et al.
Publicado: (2019)